Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter products even though strong generic competition has existed for many years. Bayer also has an economic moat in ...

Over the next five years, Bayer will face increasing generic pressures on the firm’s top two drugs (Xarelto for cardiovascular disease with major patent losses in 2026-27 and Eylea for ...

The global OTC drugs, vitamins, and dietary supplements market is poised for growth from $276.9 billion in 2025 to $371.7 billion by 2030 at a CAGR of 6.1%. Leading brands like Bayer and Procter ...

Yet a year after Anderson set out the plan for Bayer — whose products range from over-the-counter painkillers to industrial chemicals — its share price has not recovered.

On Wednesday morning, officials gathered at the large Bayer plant on West Stoever Avenue to mark a $43.6-million, 70,000-square-foot expansion to the plant where some of the most well-known over ...